US Federal 2025-2026 Regular Session

US Federal House Bill HR1133

Introduced
 
Introduced
3/24/26  

Caption

Designating November 7 of each year as ''Shwachman Diamond Syndrome Awareness Day''.

Summary

H. Res. 1133 is a simple House resolution that designates November 7 of each year as “Shwachman Diamond Syndrome Awareness Day.” The resolution states that Shwachman-Diamond syndrome (SDS) is a rare inherited genetic disorder that affects the bone marrow, pancreas, and skeleton, and it describes the condition’s symptoms, complications, and the fact that it is often underdiagnosed. It also notes that there is no cure, that treatment is focused on managing symptoms and complications, and that early diagnosis and multidisciplinary care can improve quality of life. The resolution’s stated purpose is to increase public awareness of SDS and encourage further research into effective treatments. It emphasizes the need for greater understanding of the disease and support for affected individuals and families, and it frames the awareness day as a way to promote national, state, and local initiatives related to research and education. The measure is effective immediately upon adoption and does not create a regulatory program or funding mechanism.

Impact

This resolution would not change state law or federal statutory requirements; it is a commemorative measure expressing the sense of the House and establishing an annual awareness day. Its practical effect would be symbolic and educational, potentially helping advocacy groups, medical professionals, and families draw attention to SDS, rare disease research, and patient support. Because it is a resolution, it does not mandate benefits, impose duties, or alter existing health-care or research statutes.

Sentiment

The available context suggests broadly supportive sentiment. The bill is framed in positive, noncontroversial terms around awareness, education, and support for people living with a rare disease. There are no recorded committee transcripts or votes indicating opposition, and the resolution was introduced by bipartisan sponsors. The tone of the findings is sympathetic and advocacy-oriented, emphasizing the seriousness of the condition and the value of research and early diagnosis.

Contention

There is little visible contention in the available record. The measure does not appear to raise fiscal, regulatory, or partisan disputes, and no committee debate or vote history is provided. If any issue were to arise, it would likely be limited to the general question of whether Congress should designate awareness days for specific conditions, rather than any disagreement over the substance of Shwachman-Diamond syndrome itself.

Companion Bills

No companion bills found.

Previously Filed As

US AJR119

Designates November 7 of each year as "Shwachman Diamond Syndrome Awareness Day" in NJ.

US SJR143

Designates November 7 of each year as "Shwachman Diamond Syndrome Awareness Day" in NJ.

US SJR254

Ehlers-Danlos Syndromes Awareness Month; designating as May 2025 & each succeeding year thereafter.

US HJ89

Designating May 9, in 2026 and in each succeeding year, as Long QT Syndrome Awareness Day in Virginia.

US HR903

Expressing support for the designation of November as "Complex Regional Pain Syndrome and Reflex Sympathetic Dystrophy Syndrome Awareness Month".

US HR209

Expressing support for the designation of April 5, 2025, as "Barth Syndrome Awareness Day".

US HR1060

Expressing support for the designation of April 5, 2026, as "Barth Syndrome Awareness Day".

US HR94

Designates November 16, 2026, as Sanfilippo Syndrome Awareness Day in Louisiana

US SJR49

Designates March 30th of each year "Menstrual Toxic Shock Syndrome Awareness Day."

US AJR19

Designates May 7 of each year as "Cystinosis Awareness Day" in New Jersey.

Similar Bills

No similar bills found.